Medical professionals inspect newly arrived equipment in a warehouse.
India’s drug regulator is exploring a significant policy shift that would permit hospitals to directly import advanced medical equipment, such as MRI and CT scanners. This proposed change aims to streamline the procurement process and accelerate access to cutting-edge healthcare technology within the country.
Currently, the import of such specialized equipment often requires navigating existing import license frameworks. The proposed direct import route is intended to bypass these procedures, potentially reducing lead times and making advanced diagnostic and treatment tools more readily available to healthcare institutions.
However, the move has raised concerns within India’s domestic medical device industry. Stakeholders in the local sector have voiced apprehension regarding potential safety risks associated with direct imports. They emphasize the specialized expertise required for handling high-risk medical equipment and ensuring adherence to stringent quality standards, roles currently fulfilled by licensed importers.
The debate highlights a tension between facilitating access to global medical innovations and safeguarding domestic industry interests, alongside ensuring patient safety and equipment quality through established import channels.
About the Author
